The Cannabinoid System: Potential and Implications for Health and Disease?
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 2550
Special Issue Editor
Interests: psychiatry; psychopharmacology; addiction; drugs of abuse; toxicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The cannabinoid system has increasingly attracted attention by the scientific and medical community in recent decades, since the compounds in cannabis and their biological targets are implicated in various processes of health and disease. Cannabis and its constituents (cannabinoids) have shown promise as therapeutics in cancer, inflammatory disease and multiple sclerosis. On the other hand, cannabinoids could also be beneficial for mental health, although there is not yet a scientific consensus on this subject. For instance, the main psychoactive compound, delta-9-tetrahydrocannabinol (THC), is both praised as therapeutic and scorned for its psychoactive properties, which may cause psychosis and depression. Cannabidiol (CBD), another cannabinoid, might alleviate the symptoms of mental illness. Many countries have recently adapted new legislation on cannabis, with many others to follow, and the therapeutic potential of this controversial plant to treat a plethora of health disorders is being investigated with new vigor. Therefore, we invite research groups and authors to publish new articles that shed further light on the cannabinoid system and its possible implications for health and disease.
Dr. Tibor Markus Brunt
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- THC
- CBD
- psychoactive
- disease
- disorders
- beneficial
- therapeutic
